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 Abstract 
 Background: Omega-3 polyunsaturated fatty acids (PUFA) may affect the risk of cognitive 
decline in older adults.  Methods: Cross-sectional analysis was conducted among 720 (50.4% 
women) participants aged 68–92 years (mean age: 77.6, SD ±6.2) of the population-based 
KORA-Age study. Eicosapentaenoic acid and docosahexaenoic acid (omega-3 index) were 
measured in erythrocytes as a percentage of total fatty acids. The categories low (<5.7), in-
termediate (5.7–6.8), and high (>6.8) levels of the omega-3 index were built using tertiles. The 
association between cognitive status and omega-3 levels was assessed by logistic regression 
analyses with adjustments for important concurrent risk factors of cognitive decline.  Results: 
In the sex- and age-adjusted model (model 1), subjects with a low omega-3 index were at a 
significantly higher risk for cognitive impairment (OR: 1.77, 95% CI: 1.15–2.73, p = 0.009). This 
association remained stable after further adjusting for educational level (model 2; OR: 1.75, 
95% CI: 1.13–2.71, p = 0.01) and metabolic risk factors (model 3; OR: 1.77, 95% CI: 1.14–2.75, 
p = 0.01). After further controlling for affective disorders (model 4), the association did not 
attenuate (OR: 1.77, 95% CI: 1.14–2.76, p = 0.01).  Conclusion: A robust association was found 
between low omega-3 levels and cognitive impairment in an elderly population. Further re-
search is needed to understand the link between omega-3 PUFA and cognitive functioning. 
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 Introduction 
 A growing body of evidence suggests that the two omega-3 polyunsaturated fatty acids 
(PUFA) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) could have neuropro-
tective properties  [1, 2] . With ageing, omega-3 PUFA levels in the brain tend to decrease, 
suggesting that low levels of EPA and DHA could contribute to deterioration in memory and 
other cognitive functions  [3] . Many of the benefits of DHA may be due its derivative neuro-
protection D1 (NPD1), which helps promote membrane fluidity, regulate apoptosis, and 
modulate inflammation  [4] . EPA plays a major role in the modulation of blood flow and inflam-
mation  [2] . Both EPA and DHA potentially play a role in synaptic plasticity, neurogenesis, 
cognition, and vascular health  [5, 6] .
 Notwithstanding the biological plausibility that explains the potential protective role of 
omega-3 PUFAs  [5, 6] , and despite considerable efforts in the last decade, interventional trials 
regarding the effect of omega-3 do not univocally show an inverse relation between levels of 
omega-3 PUFAs and cognitive impairment  [7–9] .
 Furthermore, population-based studies on the relationship between blood (plasma or 
erythrocyte) omega-3 PUFA composition and some form of cognitive impairment yielded 
inconclusive results  [10] , either showing a strong relationship between DHA and/or EPA and 
a vascular pattern of cognitive impairment  [11] , global cognitive function  [12] , and major 
aspects of cognitive performance  [13] or failing to show significant associations  [13] . In some 
studies, the association attenuated after adjustment for confounders  [14] . Likewise, some 
longitudinal studies revealed that lower erythrocyte EPA and DHA levels were associated 
with a higher risk of cognitive decline  [15, 16] . However, this association could not be 
confirmed by other studies  [17–19] .
 Given the controversial evidence, we hypothesized that erythrocyte EPA and DHA are 
independent predictors for cognitive impairment. Since cognitive impairment is influenced 
by a multitude of factors  [20–22] , we took special effort to control for potential confounding 
factors. As in the previous Framingham study  [11] , we chose the HS-Omega-3 Index method, 
a widely used standardized method to analyze erythrocyte fatty acid composition  [23] . Eryth-
rocyte fatty acids have a low biological variability and thus reflect tissue fatty acid compo-
sition  [24] . We report the association of erythrocyte EPA and DHA with cognitive impairment 
in a population-based sample of older subjects (n = 720 participants, mean age: 77.6 years, 
SD ±6.2).
 Methods 
 Study Setting and Population 
 The KORA (Cooperative Health Research in the Region of Augsburg)-Age study is a population-based 
study conducted in southern Germany. Between 1984/1985 and 1999/2000, four cross-sectional popu-
lation-based surveys were conducted in Augsburg and two surrounding counties with response rates from 
79% in the first survey to 67% in the fourth survey  [25] . The KORA-Age cohort includes all participants from 
those KORA surveys aged 65 years or older at the end of 2008, i.e. born in or before 1943. Details about 
KORA-Age have been reported elsewhere  [26] . Briefly, 1079 participants were examined at baseline in 2009 
(KORA-Age 1). In 2012, 822 of these participants took part in a follow-up study including a telephone 
interview, physical examinations, a face-to-face interview, and a self-assessment form (KORA-Age 2). The 
participants of KORA-Age 2 provided the data for this cross-sectional study. The examinations and the inter-
views were performed by trained and experienced staff from the KORA study center in Augsburg. All partic-
ipants had given informed consent prior to their inclusion in the study. The KORA-Age study was approved 
by the ethics committee of the Bavarian Medical Association. All investigations have been conducted according 
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 After exclusion of participants with missing data on exposure and outcome variables, the final
data set for the present analysis consisted of 720 subjects (online suppl. fig. 1; available on www.
karger.com/doi/10.1159/000448805). 
 Instruments and Procedures 
 Exposure: Omega-3 PUFA Concentration and Omega-3 Index 
 Erythrocyte fatty acid composition was analyzed according to the HS-Omega-3 Index(R) methodology 
as previously described  [27] . Fatty acid methyl esters were generated from erythrocytes by acid transester-
ification and analyzed by gas chromatography using a GC2010 Gas Chromatograph (Shimadzu, Duisburg, 
Germany) equipped with a SP2560, 100-meter column (Supelco, Bellefonte, Pa., USA) using hydrogen as 
carrier gas. Fatty acids were identified by comparison with a standard mixture of fatty acids characteristic of 
erythrocytes. Results are given as EPA plus DHA expressed as a percentage of total identified fatty acids after 
response factor correction. The coefficient of variation for EPA plus DHA was 5%. Analyses were quality-
controlled according to DIN ISO 15189. The omega-3 index was approximately normally distributed in the 
study population. The categories low (<5.7), intermediate (5.7–6.8), and high (>6.8) levels of the omega-3 
index were built using tertiles  [28] . 
 Outcome: Cognitive Status 
 Cognitive status was assessed by using the German version of the Telephone Interview for Cognitive 
Status modified (TICS-m), which includes adjustment for years of education  [29] . The instrument includes 
four cognitive domains: (a) orientation; (b) memory (registration, recent memory, and delayed recall); (c) 
attention/calculation, and (d) language (semantic memory, comprehension and repetition). The TICS-m was 
administered according to published procedures and followed a standardized script  [30] . The TICS-m score 
ranges from of 0 to 50  [29] . Normal cognitive function was defined as having  ≥ 31 of the TICS-m score; mild 
cognitive impairment was between 28 and 30, and probable dementia was  ≤ 27 of the TICS-m score  [31] . The 
variable was dichotomized into good (= normal) cognitive status (n = 561) and mildly impaired cognitive 
status/suspected dementia (n = 159). We tested for differences in the omega-3 index levels between mildly 
cognitive impaired subjects (n = 105) and subjects suffering from suspected dementia (n = 54). No difference 
was detected (χ 2 = 0.17, d.f. = 2, p = 0.92), thus supporting our decision of combining those two categories 
into one.
 Confounders 
 We chose a variety of known and potential risk factors for cognitive decline as confounders  [22] .  Socio-
economic variables  included age and sex. Living alone was recorded in the telephone interview and assessed 
by a one-item instrument with a yes/no answer. Education level  was dichotomized  in <12 years and  ≥ 12 
years of schooling.  Physical activity  was dichotomized into physically active or physically inactive. Indi-
viduals were rated as ‘active’, if they reported regularly participating in sports for 1 h/week on average 
during leisure time in either season. Current smoking was defined as regularly or occasionally smoking ciga-
rettes. Following WHO recommendations, obesity was defined as a BMI  ≥ 30 and hypertension as a (systolic/
diastolic) blood pressure  ≥ 140/90 mm Hg or taking antihypertensive medication. Total cholesterol (TC) and 
high-density lipoprotein cholesterol (HDL-C) were measured in mg/dl by enzymatic methods (CHOD-PAP; 
Boehringer, Mannheim, Germany) and combined to TC/HDL-C for the present analyses. Hypercholester-
olemia was defined as a TC/HDL-C ratio >5. Depression was measured in the telephone interview by the 
Geriatric Depression Scale (GDS-15) from Sheikh and Yesavage  [32] . This scale comprises 15 items with yes/
no answers. The maximal score is 15 points, where 0–5 indicates normal, 6–10 light-to-moderate depression, 
and 11–15 severe depression. Participants with a score  ≥ 10 were considered to have depressive symptoms. 
Anxiety was assessed using the Generalized Anxiety Disorder Scale-7 (GAD-7)  [33] . The GAD-7 consists of 7 
items with answers ranging from ‘not at all’ (0) to ‘nearly every day’ (3). Thus, the score ranges from 0 to 21. 
In the present investigation, participants with a score  ≥ 10 were considered to have anxiety. Sleep-related 
characteristics were evaluated in the interview using the Uppsala Sleep Inventory (USI)  [34] . Two separate 
3-category interview questions were asked concerning an individual’s difficulty initiating sleep (‘Do you have 
trouble falling asleep?’) and the difficulty maintaining sleep (‘Do you wake up during the night?’). Individuals 
were considered to have difficulties if they answered ‘often’ or ‘sometimes’ and were compared to partici-
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 Statistical Analysis 
 Univariate associations were assessed using the χ 2 test or Fisher exact test (in case the cell count was 
<5). To assess the association between omega-3 index levels (exposure) and cognitive status (outcome), 
multinomial logistic regression analyses with different adjustments for potential confounding factors were 
performed. The first model (model 1) was adjusted for age and sex, the second model (model 2) was addi-
tionally adjusted for education, the third model (model 3) additionally for metabolic risk factors (obesity, 
actual hypertension, hypercholesterolemia, smoking, and physical inactivity) and the final model (model 4) 
additionally for depression and anxiety.
 For all statistical analyses, a p value <0.05 was considered to be statistically significant. All evaluations 
were performed with the statistical software SAS Version 9.3 for Windows (SAS Institute, Cary, N.C., USA). 
The study follows the STROBE guidelines for observational studies  [35] .
 Results 
 Description of the Study Population 
 The population under study consisted of a total of 720 participants, among them 357 
(49.6%) men and 363 (50.4%) women in an age range between 68 and 92 years (mean age: 
77.6, SD ±6.2). The mean omega-3 index score was 6.4 (range: 3.15–12.95, SD ± 1.4). One third 
each (n = 240) of the study population showed low, intermediate, or high levels of the omega-3 
index. The characteristics of the study population stratified for omega-3 index levels are given 
in  table 1 . Compared to subjects with low levels, participants with high levels were signifi-
cantly better educated, older, and less likely to suffer from anxiety. No significant differences 
were observed regarding sex, living alone, metabolic risk factors including sleep problems, 
and depressed mood. 
 Table 1.  Association of socioeconomic, lifestyle, and metabolic risk factors with low (<5.7), intermediate 
(5.7–6.8), and high (>6.8) levels of the omega-3 index (n = 720)









Men 50.4 (121) 48.8 (117) 49.6 (119)
Women 49.6 (119) 51.2 (123) 50.4 (121)
Age 0.004
<78 years 52.1 (125) 60.0 (144) 42.5 (102)
78 – 88 years 40.0 (96) 35.0 (84) 48.8 (117)
≥88 years 7.9 (19) 5.0 (12) 8.8 (21)
Education ≥12 years 22.5 (54) 26.3 (63) 36.7 (88) 0.002
Living alone 39.2 (94) 30.0 (72) 36.3 (87) 0.10
Metabolic risk factors
Physical inactivity (sporting <1 h/week) 43.8 (105) 41.3 (99) 47.5 (114) 0.38
Current smoking 2.9 (7) 4.2 (10) 3.3 (8) 0.75
Obesity (BMI ≥30) 31.7 (76) 27.5 (66) 23.8 (57) 0.15
Hypertension (≥140/90 mm Hg) 68.3 (164) 67.1 (161) 75.8 (182) 0.08
Type 2 diabetes mellitus  15.4 (37) 16.7 (40) 15.8 (38) 0.92
Hypercholesterolemia (TC/HDL-C ratio >5) 16.7 (40) 20.4 (49) 15.0 (36) 0.28




















   
   
   
   
   
   
   
   
   
   
   





















240Dement Geriatr Cogn Disord 2016;42:236–245
 DOI: 10.1159/000448805 
 Lukaschek et al.: Cognitive Impairment Is Associated with a Low Omega-3 Index in the 
Elderly: Results from the KORA-Age Study 
www.karger.com/dem
© 2016 S. Karger AG, Basel
 Distribution of Healthy and Cognitively Impaired Participants  
 In the lowest omega-3 tertile, the percentage of cognitively impaired participants was 
highest (n = 71, 29.6%), whereas in the intermediate tertile, this percentage was 15.8% (n = 
38), and in the highest tertile it was 20.8% (n = 50). This difference of distribution was signif-
icant (χ 2 = 13.51, d.f. = 2, p = 0.001). As can be seen in  figure 1 , in each omega-3 tertile, more 
men than women were in the cognitively impaired group. However, the observed difference 
between the sexes was significant only in the lowest omega-3 tertile (χ 2 = 4.15, d.f. = 1, p = 
0.04).
 Associations of Omega-3 Index Levels with Cognitive Status by Logistic Regression 
( Table 2 ) 
 In the sex- and age-adjusted model (model 1), subjects with a low omega-3 index level 
were at a significantly higher risk for mild cognitive impairment/suspected dementia (OR: 
1.77, 95% CI: 1.15–2.73, p = 0.009). This association remained stable after further adjusting 
for educational level (model 2; OR: 1.75, 95% CI: 1.13–2.71, p = 0.01) and additionally for 
metabolic risk factors (obesity, hypertension, hypercholesterolemia, smoking, and physical 
inactivity) (model 3; OR: 1.77, 95% CI: 1.14–2.75, p = 0.01). Even after further controlling for 
affective disorders (depression and anxiety) in the final model (model 4), the association did 
not attenuate (OR: 1.77, 95% CI: 1.14–2.76, p = 0.01). The model fit for all models was suffi-
cient as indicated by the c statistic (0.69). 
 Sensitivity Analyses: Sleep Problems 
 In a reduced data set (n = 715), no significant associations were found between omega-3 


















 Fig. 1. Percentage of participants with healthy or impaired cognitive status per omega-3 index tertile (sepa-
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d.f. = 2, p = 0.17) or a combination of both (χ 2 = 3.51, d.f. = 2, p = 0.17). Impaired sleep patterns 
were not significantly associated with cognitive impairment when introduced into the final 
logistic regression model (model 4). However, even in this further adjusted models, the asso-
ciation of cognitive impairment with low omega-3 index levels remained stable (OR: 1.78, 
95% CI: 1.14–2.78, p = 0.01 when adjusting for problems initiating sleep; OR: 1.79, 95% CI: 
1.15–2.79, p = 0.01 when adjusting for problems maintaining sleep; OR: 1.78, 95% CI: 1.14–
2.77, p = 0.01 when adjusting for a combination of both). The model fit for all models was 
sufficient as indicated by the c statistic (0.69). 
 Discussion 
 A robust association between low omega-3 index levels and cognitive impairment was 
found in the present study based on data of a large, population-based sample of elderly subjects. 
The association resisted adjustment for sociodemographic and metabolic risk factors and for 
affective disorders. Our findings provide further evidence for the neuroprotective role of 
omega-3 fatty acids against cognitive decline  [3] and corroborate previously published data. 
In a cross-sectional study in dementia-free Framingham study participants (n = 1,575, mean 
age: 67 years, SD ±9), low levels of EPA and DHA in erythrocytes were associated with small 
brain volumes and a vascular pattern of cognitive impairment  [11] . Another cross-sectional 
study from Japan including 158 non-demented participants (mean age: 84.1 years, SD ±3.4) 
showed that higher global cognitive function was significantly associated with higher levels of 
serum EPA and DHA+EPA after controlling for confounders  [12] . Nonetheless, there is 
conflicting evidence from population-based studies of the relationship between blood (plasma 
 Table 2. Associations of the omega-3 index levels with cognitive decline (159 cases, 561 non-cases) adjusted 
for different risk factors (models 1 – 4)









Low 1.77, 1.15 – 2.73* 1.75, 1.13 – 2.71* 1.77, 1.14 – 2.75* 1.77, 1.14 – 2.76*
Intermediate 0.85, 0.53 – 1.38 0.84, 0.52 – 1.36 0.85, 0.52 – 1.39 0.86, 0.53 – 1.40
Ageb
77 – 88 years 2.24, 1.51 – 3.32** 2.25, 1.52 – 3.33** 2.05, 1.36 – 3.07* 2.05, 1.37 – 3.09*
≥88 years 4.90, 2.59 – 9.25** 4.85, 2.56 – 9.18** 4.14, 2.15 – 7.98** 4.15, 2.16 – 8.01**
Male 1.55, 1.07 – 2.24* 1.59, 1.08 – 2.35* 1.70, 1.14 – 2.53* 1.70, 1.14 – 2.53*
Low education – 1.09, 0.70 – 1.68 1.13, 0.73 – 1.76 1.13, 0.73 – 1.76
Physical inactivity – – 1.49, 1.01 – 2.19* 1.49, 1.01 – 2.19*
Current smoker – – 0.47, 0.13 – 1.70 0.48, 0.13 – 1.74
Obesity – – 1.03, 0.67 – 1.56 1.03, 0.67 – 1.56
Hypertension – – 1.04, 0.69 – 1.56 1.04, 0.69 – 1.56
Hypercholesterolemia – – 0.83, 0.50 – 1.37 0.83, 0.50 – 1.37
Anxiety – – – 1.16, 0.49 – 2.72
Depression – – – 0.81, 0.24 – 2.76
 Model 1 was adjusted for age and sex, model 2 was additionally adjusted for education, model 3 additionally 
for metabolic risk factors (obesity, actual hypertension, hypercholesterolemia, smoking, and physical 
inactivity), and model 4 additionally for depression and anxiety. * p < 0.05, ** p < 0.0001. a The group with 
the highest omega-3 index level (>6.8) was the reference group. b The youngest age group (<77 years of age) 
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or erythrocyte) omega-3 PUFA composition and some form of cognitive impairment. A study 
from Italy (n = 935, age >65 years) found that participants with dementia had significantly 
lower omega-3 PUFA levels (although not EPA and DHA specifically) than participants with 
normal cognitive function after adjustment for confounders  [14] . Furthermore, there was no 
statistical difference regarding omega-3 PUFAS between cognitively impaired and normal 
participants  [14] . Another cross-sectional study found DHA, but not EPA, to be associated with 
major aspects of cognitive performance in healthy adults (n = 280) <55 years of age  [13] . 
Support for our findings also comes from longitudinal studies. In a 4-year follow-up time of 
246 men and women aged 63–75 years, lower erythrocyte EPA and DHA were associated with 
a higher risk of cognitive decline  [15] . This, however, could not be confirmed in an observation 
of 663 initially non-demented subjects ( ≥ 65 years of age)  [17] . In a US study, lower plasma 
levels of DHA and EPA were associated with a higher risk of decline in verbal fluency, particu-
larly in hypertensive and dyslipidemic subjects, but not with changes in psychomotor speed 
or delayed word recall in a 11-year follow-up (n = 2,251, age >50 years)  [16] .
 In the multivariate model, we controlled for a variety of factors known to have an inde-
pendent impact on cognitive decline. Male sex and increasing age were strongly associated 
with cognitive impairment in all models, thereby corroborating previous results  [20, 36] . 
Furthermore, physical inactivity was significantly associated with cognitive impairment; 
physical activity has been found to be a protective factor against cognitive decline  [20] . 
Although sustained exposure to smoking and hypertension  [20, 21, 37, 38] has been confirmed 
risk factors for cognitive decline, we did not find a significant association in our models. 
Furthermore, other risk factors such as low education or obesity  [20, 21] , hypercholester-
olemia  [39] , depressive mood  [22] , or difficulty in maintaining sleep  [40] were not signifi-
cantly associated with cognitive impairment in the present study.
 In our sample, omega-3 levels were surprisingly high among the older-age groups. We 
cannot explain this finding, which contrasts the general scientific opinion promoting that the 
content of omega-3 PUFA in the human brain generally increases with age over the first 2 
decades and then levels off  [41] or even drops  [3, 12] . However, previous research on cardio-
vascular patients has shown that a higher omega-3 index was associated with longer survival 
 [42] .
 Interestingly, we found a significant association of high levels of the omega-3 index and 
better education. Comparable findings came from the Heart and Soul Study, where low 
education levels were associated with low levels of DHA and EPA  [43] . Although there is still 
debate on the social determination of taste and food preferences and their impact on nutri-
tional balance  [44] , one can assume that subjects with better education, i.e. higher social 
status, are better informed of healthy dietary components. Following Darmon et al.  [45] , 
higher-quality diets are, in general, consumed by better-educated and more affluent people. 
Conversely, lower quality diets tended to be consumed by groups of lower socioeconomic 
status and more limited economic means. However, it is of note that a substantial proportion 
of our study population received their education during World War II and in the immediate 
post-war period when little choice was possible in food. Furthermore, the intake of EPA and 
DHA is only one determinant of the omega-3 index  [46] .
 Potential Mechanisms Underlying the Link between Cognitive Functioning and PUFA 
 The potential cognitive benefit of omega-3 PUFA  may result from targeted modulation of 
neurogenesis and synaptic plasticity in brain regions that are particularly susceptible to 
oxidative stress and amyloid burden  [6, 7] . As such, the hippocampus, a region thought to 
govern verbal recall, is sensitive to age-associated brain atrophy in both healthy and impaired 
individuals  [7, 47] . As has been shown, the omega-3 index was positively related to brain and 
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 Recommendations 
 In our study, a low omega-3 index was a powerful predictor of cognitive impairment (OR: 
1.77). Increasing the omega-3 index by increased intake of EPA and DHA is easily feasible  [49, 
50] . Moreover, a dose of up to 3 g EPA and DHA per day is considered safe by the Federal Drug 
Administration and up to 5 g per day by its European counterpart, the European Food Safety 
Authority  [23] . However, issues in bioavailability and a large interindividual variability in the 
uptake of ingested EPA and DHA suggest an individually targeted approach towards dosing 
of EPA and DHA. Earlier, we suggested a target range for the omega-3 index of 8–11% for the 
cardiovascular area  [49] . The present data, with a mean of the upper tertile of 8.02 ± 1.02, 
support this target range in the area of cognitive impairment. Surprisingly, the general public 
does not associate diet habits with dementia  [51] .
 Strengths and Limitations 
 The strength of the study is the focus on elderly subjects taken from a well-established, large 
population-based data set and the use of a reliable biological measure of omega-3 fatty acid levels. 
A further strength is the use of a validated instrument to assess cognitive status: the TICS-m  [29] . 
This instrument includes the four cognitive domains orientation, memory, attention/calculation, 
and language and has been performed in population-based studies under strict assessment regu-
lation and quality control. Furthermore, the erythrocyte membrane fatty acid composition is 
biologically rather stable: omega-3 PUFAs from red blood cells can be used as biochemical indi-
cators of their corresponding midterm (60–90 days) dietary intakes  [15] . This is an advantage to 
plasma fatty acid concentrations, which fluctuate according to shorter-term intake  [52] .
 Limitations have to be considered, however. We cannot address the impact of the dietary 
intake of omega-3 PUFAs in the KORA age study  [53] . Reverse causation, although highly 
unlikely, cannot be ruled out. Although the demographic and socioeconomic characteristics 
of the study population roughly reflect those of the average central European population in 
general, differences in diet between countries may limit generalizability.
 Conclusion 
 Low omega-3 index levels are robustly associated with cognitive impairment in the 
present investigation. This association was not influenced by a variety of confounding factors. 
Further research is needed to better understand the role of omega-3 PUFA in ageing brain 
physiology and to explain the link between omega-3 PUFA and cognitive functioning. Our data 
support the usefulness of conducting an intervention trial with omega-3 fatty acids in the 
prevention of cognitive impairment, targeting an omega-3 index of 8–11%.
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